EFG
Ethos Financial Group’s Lixte Biotechnology LIXT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.5K | Hold |
24,808
| – | – | ﹤0.01% | 462 |
|
|
2025
Q1 | $50.4K | Hold |
24,808
| – | – | ﹤0.01% | 432 |
|
|
2024
Q4 | $50.4K | Hold |
24,808
| – | – | 0.01% | 342 |
|
|
2024
Q3 | $46K | Hold |
24,808
| – | – | 0.01% | 293 |
|
|
2024
Q2 | $59K | Hold |
24,808
| – | – | 0.01% | 278 |
|
|
2024
Q1 | $84K | Buy |
+24,808
| New | +$84K | 0.02% | 274 |
|
|
2023
Q4 | – | Sell |
-24,808
| Closed | -$60.8K | – | 285 |
|
|
2023
Q3 | $60.8K | Sell |
24,808
-223,276
| -90% | -$547K | 0.02% | 176 |
|
|
2023
Q2 | $205K | Hold |
248,084
| – | – | 0.07% | 138 |
|
|
2023
Q1 | $205K | Hold |
248,084
| – | – | 0.06% | 168 |
|
|
2022
Q4 | $126K | Buy |
+248,084
| New | +$126K | 0.04% | 141 |
|